| Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 (NCT02981797) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-22 |
| Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) (NCT02402764) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-08 |
| A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML (NCT02403310) | H. Lee Moffitt Cancer Center and Research Institute | 2015-06-18 |
| Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer (NCT02415621) | H. Lee Moffitt Cancer Center and Research Institute | 2015-04-13 |
| Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes (NCT02416011) | H. Lee Moffitt Cancer Center and Research Institute | 2015-03-31 |
| Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database (NCT02708381) | H. Lee Moffitt Cancer Center and Research Institute | 2015-03-19 |
| Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer (NCT02292173) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-18 |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer (NCT02300610) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-11 |
| Smoking Cessation for Cervical Cancer Survivors (NCT02157610) | H. Lee Moffitt Cancer Center and Research Institute | 2015-01-01 |
| Focal Prostate Radio-Frequency Ablation (NCT02328807) | H. Lee Moffitt Cancer Center and Research Institute | 2014-12-29 |
| Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus (NCT02283359) | H. Lee Moffitt Cancer Center and Research Institute | 2014-12-01 |
| BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer (NCT02155088) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-30 |
| Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease (NCT01795573) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-29 |
| Capitalizing on a Teachable Moment to Promote Smoking Cessation (NCT02276664) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-20 |
| Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases (NCT02187822) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-09 |
| Biomarker Correlates of Hypoxia in Metastatic Melanoma (NCT02061007) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-01 |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer (NCT02063724) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-01 |
| Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma (NCT02186834) | H. Lee Moffitt Cancer Center and Research Institute | 2014-09-23 |
| Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer (NCT02139358) | H. Lee Moffitt Cancer Center and Research Institute | 2014-09-05 |
| Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma (NCT02218164) | H. Lee Moffitt Cancer Center and Research Institute | 2014-08-12 |
| COGNUTRIN in Breast Cancer Survivors (NCT01823991) | H. Lee Moffitt Cancer Center and Research Institute | 2014-07-30 |
| Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence (NCT02202499) | H. Lee Moffitt Cancer Center and Research Institute | 2014-07-17 |
| Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck (NCT02158234) | H. Lee Moffitt Cancer Center and Research Institute | 2014-07-16 |
| Single Agent Regorafenib in Refractory Advanced Biliary Cancers (NCT02115542) | H. Lee Moffitt Cancer Center and Research Institute | 2014-06-05 |
| Navigator Guided e-Psychoeducational Intervention (NCT02186444) | H. Lee Moffitt Cancer Center and Research Institute | 2014-06-02 |
| A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS (NCT02336984) | H. Lee Moffitt Cancer Center and Research Institute | 2014-06-01 |
| Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer (NCT02138383) | H. Lee Moffitt Cancer Center and Research Institute | 2014-05-22 |
| Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) (NCT03078361) | H. Lee Moffitt Cancer Center and Research Institute | 2014-04-28 |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy (NCT02061423) | H. Lee Moffitt Cancer Center and Research Institute | 2014-04-08 |
| Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 (NCT01841021) | H. Lee Moffitt Cancer Center and Research Institute | 2014-04-01 |
| In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis (NCT01927120) | H. Lee Moffitt Cancer Center and Research Institute | 2014-03-25 |
| Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma (NCT02032810) | H. Lee Moffitt Cancer Center and Research Institute | 2014-01-07 |
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) (NCT01999985) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-31 |
| A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation (NCT01859026) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-30 |
| Physical Activity for Advanced Stage Cancer Patients (NCT02015936) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-12 |
| P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome (NCT01886287) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-01 |
| Yoga for Aromatase Inhibitor-associated Joint Pain (NCT01951976) | H. Lee Moffitt Cancer Center and Research Institute | 2013-09-01 |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain (NCT01846429) | H. Lee Moffitt Cancer Center and Research Institute | 2013-09-01 |
| Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) (NCT01842646) | H. Lee Moffitt Cancer Center and Research Institute | 2013-08-29 |
| Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection (NCT01873573) | H. Lee Moffitt Cancer Center and Research Institute | 2013-07-18 |
| Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS) (NCT01822691) | H. Lee Moffitt Cancer Center and Research Institute | 2013-07-01 |
| Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer (NCT03077126) | H. Lee Moffitt Cancer Center and Research Institute | 2013-04-11 |
| Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly (NCT01671813) | H. Lee Moffitt Cancer Center and Research Institute | 2013-03-01 |
| Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (NCT01713400) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-25 |
| Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients (NCT01702064) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-21 |
| A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib (NCT01776723) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-20 |
| Study of Gardasil in Mid-Adult Males (MAM) (NCT01432574) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-19 |
| A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients (NCT01795586) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-06 |
| GTX-RT in Borderline Resectable Pancreatic Cancer (NCT01754623) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-01 |
| Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (NCT01852591) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-01 |
| Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study (NCT01760499) | H. Lee Moffitt Cancer Center and Research Institute | 2013-01-24 |
| C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer (NCT01302821) | H. Lee Moffitt Cancer Center and Research Institute | 2013-01-01 |
| Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies (NCT01683149) | H. Lee Moffitt Cancer Center and Research Institute | 2013-01-01 |
| Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease (NCT01680965) | H. Lee Moffitt Cancer Center and Research Institute | 2012-11-14 |
| Pilot Study of Regional Lung Ventilation (NCT03077113) | H. Lee Moffitt Cancer Center and Research Institute | 2012-10-15 |
| Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts (NCT01701674) | H. Lee Moffitt Cancer Center and Research Institute | 2012-10-09 |
| Metformin in Children With Relapsed or Refractory Solid Tumors (NCT01528046) | H. Lee Moffitt Cancer Center and Research Institute | 2012-09-24 |
| Preparedness Study - HPV Vaccine (NCT01489527) | H. Lee Moffitt Cancer Center and Research Institute | 2012-09-01 |
| Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma (NCT01659151) | H. Lee Moffitt Cancer Center and Research Institute | 2012-08-03 |
| Genetic Counseling for Breast Cancer Survivors (GC for BC) (NCT02451735) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-27 |
| Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma (NCT01657591) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-27 |
| Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma (NCT01606345) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-01 |
| Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA (NCT01531205) | H. Lee Moffitt Cancer Center and Research Institute | 2012-05-01 |
| Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets (NCT01581307) | H. Lee Moffitt Cancer Center and Research Institute | 2012-04-01 |
| Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL (NCT01496976) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-30 |
| Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer (NCT01433172) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-26 |
| Stress Management Training for Latinas Receiving Chemotherapy (NCT01599520) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-13 |
| Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer (NCT01434550) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-01 |
| Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma (NCT01496807) | H. Lee Moffitt Cancer Center and Research Institute | 2012-02-17 |
| Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (NCT01497496) | H. Lee Moffitt Cancer Center and Research Institute | 2012-01-26 |
| Smoking Relapse-Prevention Intervention for Cancer Patients (NCT01630161) | H. Lee Moffitt Cancer Center and Research Institute | 2012-01-04 |
| Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks (NCT03078348) | H. Lee Moffitt Cancer Center and Research Institute | 2011-12-05 |
| Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer (NCT01373294) | H. Lee Moffitt Cancer Center and Research Institute | 2011-11-30 |
| Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide (NCT01432600) | H. Lee Moffitt Cancer Center and Research Institute | 2011-11-01 |
| A Study of Axitinib in Advanced Carcinoid Tumors (NCT01435122) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-25 |
| Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC (NCT01437605) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-11 |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects (NCT01450046) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-01 |
| Phase I Trial of Combination of FOLFIRI and SOM 230 (NCT01434069) | H. Lee Moffitt Cancer Center and Research Institute | 2011-09-01 |
| Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects (NCT01446952) | H. Lee Moffitt Cancer Center and Research Institute | 2011-09-01 |
| Pilot Study on Focal Prostate Radio-Frequency Ablation (NCT01423006) | H. Lee Moffitt Cancer Center and Research Institute | 2011-08-01 |
| Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01324180) | H. Lee Moffitt Cancer Center and Research Institute | 2011-07-18 |
| Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy (NCT01422993) | H. Lee Moffitt Cancer Center and Research Institute | 2011-07-01 |
| Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids (NCT01256268) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-13 |
| Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer (NCT01376453) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-01 |
| SOM 230 and Gemcitabine in Advanced Pancreatic Cancer (NCT01385956) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-01 |
| Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia (NCT01286038) | H. Lee Moffitt Cancer Center and Research Institute | 2011-04-06 |
| Colorectal Cancer Awareness, Research, Education and Screening (CARES) (NCT01804179) | H. Lee Moffitt Cancer Center and Research Institute | 2011-02-11 |
| Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) (NCT01253161) | H. Lee Moffitt Cancer Center and Research Institute | 2011-02-01 |
| Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) (NCT01347034) | H. Lee Moffitt Cancer Center and Research Institute | 2011-01-01 |
| Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma (NCT01253148) | H. Lee Moffitt Cancer Center and Research Institute | 2011-01-01 |
| Nuvigil or Placebo in Newly Diagnosed Malignant Glioma (NCT01400958) | H. Lee Moffitt Cancer Center and Research Institute | 2010-12-01 |
| Evaluating Biobanking Educational Tools (NCT01672944) | H. Lee Moffitt Cancer Center and Research Institute | 2010-09-27 |
| FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer (NCT01175291) | H. Lee Moffitt Cancer Center and Research Institute | 2010-09-01 |
| Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors (NCT01455311) | H. Lee Moffitt Cancer Center and Research Institute | 2010-09-01 |
| Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma (NCT01176474) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-13 |
| Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 (NCT01176461) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-04 |
| Promoting a Healthier Lifestyle Among Breast Cancer Survivors (NCT01419613) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-01 |
| Gem-TABS in Unresectable Pancreatic Carcinoma (NCT01198821) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-01 |
| Bicarbonate for Tumor Related Pain (NCT01350583) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-01 |
| Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures (NCT01175278) | H. Lee Moffitt Cancer Center and Research Institute | 2010-07-01 |